关注
Joel Francesqui
Joel Francesqui
在 santpau.cat 的电子邮件经过验证
标题
引用次数
引用次数
年份
Risk and outcome of COVID-19 infection in sarcoidosis patients: results of a self-reporting questionnaire
RP Baughman, EE Lower, M Buchanan, P Rottoli, M Drent, J Sellares, ...
Sarcoidosis, Vasculitis, and Diffuse Lung Diseases 37 (4), 2020
452020
The impact of demographic disparities in the presentation of sarcoidosis: a multicenter prospective study
Y Zhou, AK Gerke, EE Lower, A Vizel, D Talwar, I Strambu, J Francesqui, ...
Respiratory medicine 187, 106564, 2021
392021
Home oxygen monitoring in patients with interstitial lung disease
SC Cardeñosa, M Palomo, J Francesqui, X Alsina, C Hernández, ...
Annals of the American Thoracic Society 19 (3), 493-497, 2022
122022
Current treatment of sarcoidosis
J Sellarés, J Francesqui, M Llabres, F Hernandez-Gonzalez, ...
Current Opinion in Pulmonary Medicine 26 (5), 591-597, 2020
92020
Personalized medicine in sarcoidosis: unravelling biomarkers for targeted care
J Francesqui, P Marrades, J Sellares
Current opinion in pulmonary medicine 29 (5), 478-484, 2023
82023
Improving home oxygen therapy in patients with interstitial lung diseases: application of a noninvasive ventilation device
S Cuerpo, M Palomo, F Hernández-González, J Francesqui, N Albacar, ...
Therapeutic Advances in Respiratory Disease 14, 1753466620963027, 2020
52020
Prognostic factors of progressive fibrotic hypersensitivity pneumonitis: a large, retrospective, multicentre, observational cohort study
E Cano-Jiménez, AV Gómez, EV Segovia, MA Barrenechea, JS Torres, ...
ERJ Open Research 10 (1), 2024
32024
Pulmonary rehabilitation in sarcoidosis: A systematic review and meta-analysis
X Alsina-Restoy, R Torres-Castro, E Caballería, E Gimeno-Santos, ...
Respiratory Medicine, 107432, 2023
32023
Is Carob Flour Helpful in Reducing Diarrhoea Associated With Nintedanib?
X Alsina-Restoy, R Torres-Castro, E Caballería, M Sisó-Comabella, ...
Archivos de bronconeumologia 59 (5), 341-343, 2023
32023
Sarcoidosis phenotypes
J Francesqui, F Hernández-González, J Sellarés
Open Respiratory Archives 3 (4), 2021
32021
Breaking barriers: holistic assessment of ability to work in patients with sarcoidosis
M Drent, AM Russell, LA Saketkoo, P Spagnolo, M Veltkamp, AU Wells, ...
The Lancet Respiratory Medicine 12 (11), 848-851, 2024
12024
The current state-of-the-art in pharmacotherapy for pulmonary sarcoidosis
MC Mata Salvador, J Francesqui, J Sellarés
Expert Opinion on Pharmacotherapy 25 (10), 1317-1324, 2024
12024
High Follow-up Rate in Smokers With Diffuse Interstitial Lung Diseases: A Magnificent Opportunity for Tobacco Cessation Treatment?
A Frino-García, F Hernández-González, N Albacar, J Francesqui, ...
Open Respiratory Archives 6 (1), 100292, 2023
12023
Current treatment of sarcoidosis
P MARRADES, JP OROZCO, J FRANCESQUI, J SELLARES
Minerva 62 (3), 126-34, 2023
12023
Identification of indoor fungal antigens in assessment of hypersensitivity pneumonitis–an alternate approach
FIH Gonzalez, MA Calvo, LA Angulo, M Sanchez, M Benegas, J Ramirez, ...
European Respiratory Journal 54 (suppl 63), 2019
12019
Integrated care model between pneumology and primary care: Impact in respiratory diseases control
J Francesqui, J Sellarés, N Soler, C Lucena, C Embid, M Dalmases, ...
European Respiratory Journal 44 (Suppl 58), 2014
12014
Older Patients With Interstitial Lung Disease Feature a Distinct Clinical Profile
L Feltrer-Martínez, S Orozco, A Alonso, P Millan-Billi, S Barril, G Ruibal, ...
Open Respiratory Archives 6 (4), 100374, 2024
2024
Open Respiratory Archives
L Feltrer-Martínez, S Orozco, A Alonso, P Millan-Billi, S Barril, G Ruibal, ...
2024
Pulmonary rehabilitation in sarcoidosis: a systematic review and meta-analysis
EC Lamelas, XA Restoy, RT Castro, EG Santos, LS Navarro, J Francesqui, ...
European Respiratory Journal 62 (suppl 67), 2023
2023
Clinical characterisation of thoracic sarcoidosis in Spain
J Francesqui, E Bollo, A Villar, P Flórez, E Balcells, G Castaño, J Pinillos, ...
European Respiratory Journal 62 (suppl 67), 2023
2023
系统目前无法执行此操作,请稍后再试。
文章 1–20